Inspections, Compliance, Enforcement, and Criminal Investigations
3CPM Company Inc - Close Out 12/13/10
| Public Health Service Food and Drug Administration |
| Baltimore District Office 6000 Metro Drive, Suite 101 Baltimore, MD 21215 Telephone: (410) 779-5454 Fax: (410) 779-5703 |
FEI: 3002900388
December 13, 2010
CERTIFIED MAIL
RETURN RECEIPT REQUESTED
Dr. Mark D. Noar, CEO and Chairman
3CPM, Inc.
7402 York Road #100
Towson, MD 21204-7532
Dear Dr. Noar:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter 89144 dated March 25, 2010. Based on our evaluation, it appears that you have adequately addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/s/
Anne Aberdeen
Compliance Officer
Baltimore District





Department of Health and Human Services

